Skip to content
Search
Home
About Us
About APLAR
APLAR Milestones
President Message
Committees
APLAR Directors
Executive Committee
Other Committees
Membership
Member National Organizations
Constitution & Terms of Reference
Membership Application
Membership Update
Academy
APLAR Academy
Governance
Membership
Short Course
Upcoming Course
Past Course
Academy Webinar
Upcoming Webinar
Past Webinar
Grand Round
Upcoming Grand Round
Past Grand Round
Discussion Forum
Grand Round Blackboard
ASPIRE Grant
About APLAR ASPIRE
ASPIRE Core Training Modules
ASPIRE Implementation Toolkit
About SIG
AYR
ABOUT AYR
AYR Board
Committee
AYR Membership
AYR Webinar
Upcoming Webinar
Past Webinar
AYR Blackboard
Discussion Forum
Collaboration
APLAR ESOR
ESOR Application
Post Event Submission
Online Submission
EULAR School of Rheumatology
Exchange Programme
Exchange Programe Application
Online Submission
EULAR Exchange Program
APLAR MNO Patronage
Patronage Application
Online Submission
EULAR Collaborations
Center Of Excellence
APLAR CoEs
New Application
Renew CoE Application
Online Submission
Grants and Awards
Grant
COPCORD Grant
Congress Travel Grant
Research Grant
Fellowship Grant
Award
Master Award
Events
Congress
Upcoming Congress
Past Congress
Events
Upcoming Events
Past Events
Gallery
Publications
Published Journal
SIG Publication
COVID – 19 Publication
IJRD
Voice Of APLAR
Patient Education
MCQs AXSPA Blackboard Questions
Step
1
of
2
50%
Please answer with true or false to following statements on Axial Spondyloarthritis
Question 1
Which of these statements is TRUE?
Question 1
*
A. The most appropriate for monitoring Active or stable nr-Axial Spa is repeating MRI every 6 months.
B. The longer use of NSAIDs in Axial Spa is safe and do not have increased CVS risk
C. Inflammatory bowel disease, Gastroesophageal reflux, anterior uveitis and dactylitis are all expected associations of Axial Spondyloarthritis.
D. In Axial Spa refractory to NSAID, csDMARDS or TNFi should be the next step of treatment
E. Passive physical therapy modalities (massage or Ultrasonography) are most effective in patients with nr-SpA
Answer with a detailed explanation
C: Inflammatory bowel disease, Gastroesophageal reflux, anterior uveitis and dactylitis are all expected associations of Axial Spondyloarthritis.
Reference:
Dactylitis although infrequent but a recognised feature of Axial SpA (not only psoriatic arthritis)
ASAS clinical features description
Your Answer is Incorrect
- Specific References: ASAS EULAR recommendations 2022
- A- Recommendation 2
Your Answer is Incorrect
- Specific References: ASAS EULAR recommendations 2022
B- Recommendation 5
Your Answer is Incorrect
- Specific References: ASAS EULAR recommendations 2022
D- Recommendation 8
Your Answer is Incorrect
- Specific References: ASAS EULAR recommendations 2022
E- Recommendation 4 Regular exercise (not passive massage)
Question 2
Q2 Which of these statements is TRUE?
Question 2
*
A. IL-17i are superior to TNFi in halting the progression of disease and reduce BME lesions.
B. HLA B27 Positive in Axial SpA in more than 80% in all ethnic groups.
C. Nr-SpA could progress to Axial Spa in around 50% in 3 years.
D. In addition to morning stiffness and pain, fatigue is the most common additional symptoms.
E. Leeds enthesitis score (LEI) is more comprehensive than SPARCC enthesitis score
F. The response of nr-Spa to biologic therapy is better in women than men.
Answer with a detailed explanation
D. In addition to morning stiffness and pain, fatigue is the most common additional symptoms
Nr-Spa progress to Axial Spa around 15-30% in 2-5 in different studies
HLA B27 positivity can be more than 80% in european/ north american population, but is only about 20-40% in several Middle East studies.
IL17i and TNFi are comparable in the degree of radiological progression
SPARCC enthesitis score cover more points (18) compare to Leeds score (6)
Fatigue is part of regular assessment in clinical trials as features described by ASAS.
Your Answer is Incorrect
Specific References:
A- Recommendation 9ASAS EULAR recommendations 2022
Your Answer is Incorrect
Specific References:
- B- Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study, Anna Boel
Your Answer is Incorrect
Specific References:
C- Progression of patients with non-radiographic Axial Spondyloarthritis to axial spondyloarthritis: A POPULATION-BASED COHORT STUDY. Rushing Wang
Your Answer is Incorrect
Specific References:
E- Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab. Philip Mease.
Your Answer is Incorrect
Specific References:
- F- Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky. T Rusman
If you can’t view the question please click
here
.